
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Department of Pediatrics and School of Public Health, Columbia University, New York, New York [M. O.]; Instituto de Fisiología Celular, Universidad Nacional Autonoma de México, México D.F., Mexico [V. P. C.]; Departments of Pathology [C. R.], Social Work [E. L.], and Pediatric Oncology [C. L.], Instituto Nacional de Pediatría, México D.F., Mexico; Ophthalmic Oncology Center, New York Presbyterian Hospital-Cornell University Medical Center, New York, New York 10021 [D. H. A.]; and Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [I. O., W. G., C. C-C.]
Epidemiological studies have shown that the use of barrier methods of contraception is associated with a decreased incidence of papilloma virus infection and reduced risk of having a child with retinoblastoma. Thirty-nine primary retinoblastomas were analyzed for the presence of papilloma virus sequences. Tumor tissue sections were also used to assess the expression of the retinoblastoma protein and proliferative index. Papilloma sequences were detected in 14 of 39 (36%) tumors. Tumors in which viral sequences were detected were associated with a lower proliferative index (68% versus 78%; P = 0.015). Children with tumors containing viral sequences had a lower risk of extraocular disease (odds ratio, 9.0; 95% confidence interval, 1.649; P = 0.008) and a lower birth weight (2.9 versus 3.5 kg; P = 0.030). Based on these data, it is our hypothesis that papilloma viruses may play a role in the development of sporadic retinoblastoma. Detection of papilloma virus sequences and retinoblastoma protein in certain primary lesions suggests an alternative mechanism of tumor development for sporadic retinoblastoma.
This article has been cited by other articles:
![]() |
M. Chintagumpala, P. Chevez-Barrios, E. A. Paysse, S. E. Plon, and R. Hurwitz Retinoblastoma: Review of Current Management Oncologist, October 1, 2007; 12(10): 1237 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Gillison and K. V. Shah Chapter 9: Role of Mucosal Human Papillomavirus in Nongenital Cancers J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 57 - 65. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |